This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, National Cancer Center, Hankook Tire Co., Ltd.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 655 
2 out of 264 
1 out of 167 
Years Active: 2018-2022
Title: Seong Jun Park: Innovator in Anticancer Research
Introduction
Seong Jun Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical compositions aimed at treating and preventing cancer. With a total of 4 patents to his name, Park's work is recognized for its innovative approach to combating cancer.
Latest Patents
Among his latest patents, Park has developed an anticancer pharmaceutical composition that provides a method for treating or preventing cancer. This composition contains a compound with a specific chemical structure that inhibits the formation of a c-Myc/Max/DNA complex, or a pharmaceutically acceptable salt thereof. Additionally, he has disclosed novel compounds with specific chemical structures that exhibit inhibitory activity on c-Myc/Max/DNA complex formation, further contributing to the fight against cancer.
Career Highlights
Seong Jun Park has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and the National Cancer Center. His research has focused on innovative solutions to complex medical challenges, particularly in oncology.
Collaborations
Throughout his career, Park has collaborated with notable colleagues, including Kyung Chae Jeong and Hwan Jung Lim. These partnerships have enhanced his research efforts and contributed to the advancement of cancer treatment methodologies.
Conclusion
Seong Jun Park's innovative work in anticancer research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for new treatments and hope for cancer patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile